(24 days)
Not Found
No
The document describes a combined PET/CT scanner and its intended use, device description, and changes made for cost reduction and serviceability. There is no mention of AI or ML in the provided text.
No.
The device is used for imaging and diagnostic purposes to determine various metabolic and physiologic functions, not for treating diseases or conditions.
Yes
Explanation: The "Intended Use / Indications for Use" section states that the device is used "for the purpose of determining various metabolic (molecular) and physiologic functions within the human body" and to "produce cross-sectional images of the body." This information is used by trained healthcare professionals to diagnose conditions. Additionally, the "Device Description" states that the system "is intended for use as a clinical, whole-body oncology machine" and maintains "independent functionality of the PET and CT scanning systems, allowing for most standard stand-alone CT and PET clinical diagnostic protocols to be available." These uses are explicitly diagnostic in nature.
No
The device description clearly states it is a combined PET and CT scanner, which are hardware devices. The changes mentioned are related to the physical gantry and patient handling system, further indicating it is a hardware device.
Based on the provided text, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs analyze samples taken from the human body (like blood, urine, tissue). The description clearly states that this device images and measures the distribution of injected radiopharmaceuticals within the human body and produces cross-sectional images of the body using X-rays. This is an in vivo (within the living body) diagnostic process, not in vitro (in glass or outside the living body).
- The intended use and device description focus on imaging and anatomical/metabolic function within the patient. There is no mention of analyzing biological samples.
Therefore, the CPS LSO PET/CT HiRez Series Scanners are diagnostic imaging devices, not IVDs.
N/A
Intended Use / Indications for Use
The CPS LSO PET/CT HiRez Series Scanners are combined positron emission tomography (PET) and X-ray computed tomography (CT) scannesr. The LSO PET/CT scanner is intended to be utilized by appropriately trained health care professionals to 1) image and measure the distribution of injected positron emitting radiopharmaceuticals in humans for the purpose of determining various metabolic (molecular) and physiologic functions within the human body, and 2) to produce cross-sectional images of the body by computer reconstruction of x-ray prounds sion data from either the same axial plane taken at different angles or spiral planes* taken at different angles.
The PET and the CT functions of this system can also be used in combination to provide high resolution, noise free CT attenuation correction maps for PET images and, additionally, utilized to produce fused CT and PET images, providing detailed anatomic and metabolic function information in a single image.
(*spiral planes: the axial planes resulted from the continuous rotation of detectors and x-ray tube and the simultaneous translation of the patient.)
Product codes (comma separated list FDA assigned to the subject device)
KPS, JAK
Device Description
The CPS LSO PET/CT Hi-Rez series of scanners are combined Positron Emission Tomography and X-Ray Computed Tomography scanners. These systems are designed for whole-body oncology, neurology and cardiology syotome are a signiture registration and fusion of high-resolution metabolic and anatomic information from the two major components of each system, the and anatomic informanner and the Siemens Somatom CT (either Emotion or Sensation depending on the specific model).
The combined PET/CT scanner is intended for use as a clinical, whole-body oncology machine with high-end spiral CT and PET performance. The CT oncology maonine mans, quiet attenuation correction for PET studies as well as oomponont provided farmer through fused PET and CT images. In addition, the PET / CT system maintains independent functionality of the PET and CT scanning systems, allowing for most standard stand-alone CT and PET clinical diagnostic protocols to be available as well.
Changes incorporated in this system are the result of a cost reduction effort Changes incorporated in this System are the roomtry to be modified easily.
combined with changes that allow the "look" of the gantry to be interest Combined with chunges that and rain and and acturability and Adultional changes were intorporation to inipes were . These changes were
serviceability as well as to deal with parts obsolescence. (RUC) The City Serviceability as well as to deal with parts esset Handling System (PHS). The CT
limited to the PET gantry as well as the Patient Handling System (PHS). The CT illined to the F LT gamry as well as the reviously commercially available systems.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Positron Emission Tomography (PET), X-Ray Computed Tomography (CT)
Anatomical Site
whole-body
Indicated Patient Age Range
Not Found
Intended User / Care Setting
appropriately trained health care professionals
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1200 Emission computed tomography system.
(a)
Identification. An emission computed tomography system is a device intended to detect the location and distribution of gamma ray- and positron-emitting radionuclides in the body and produce cross-sectional images through computer reconstruction of the data. This generic type of device may include signal analysis and display equipment, patient and equipment supports, radionuclide anatomical markers, component parts, and accessories.(b)
Classification. Class II.
0
MAR 2 5 2005
510(K) SUMMARY
(As required by 21 CFR 807.87(h))
ldentification of Submitter
Submitter:
M. Alaine Medio, RAC Senior Regulatory Affairs Specialist CTI Molecular Imaging, Inc. 810 Innovation Drive Knoxville, TN 37932 (865)218-2703 (865)218-3019
Telephone Number: Fax Number: Date of Submission:
Identification of the Product
| Device Proprietary Name: | LSO PET/CT HiRez Series |
|---|---|
| Common Name: | Combination Positron Emission Tomography |
| (PET) and Computed Tomography (CT) | |
| Systems | |
| Classification Name: | Emission Computed Tomography System |
| per 21 CFR 892.1200 |
Marketed Devices to which Equivalence is Claimed
| Device | Manufacturer | 510(k) Number |
|---|---|---|
| LSO PET/CT HiRez and | ||
| HiRez16 | CTI PET Systems (CPS) | K033431 |
| LSO PET/CT HiRez 64 | CTI PET Systems (CPS) | K042467 |
Device Description:
The CPS LSO PET/CT Hi-Rez series of scanners are combined Positron Emission Tomography and X-Ray Computed Tomography scanners. These systems are designed for whole-body oncology, neurology and cardiology syotome are a signiture registration and fusion of high-resolution metabolic and anatomic information from the two major components of each system, the and anatomic informanner and the Siemens Somatom CT (either Emotion or Sensation depending on the specific model).
The combined PET/CT scanner is intended for use as a clinical, whole-body oncology machine with high-end spiral CT and PET performance. The CT oncology maonine mans, quiet attenuation correction for PET studies as well as oomponont provided farmer through fused PET and CT images. In addition, the PET / CT system maintains independent functionality of the PET and CT scanning systems, allowing for most standard stand-alone CT and PET clinical diagnostic protocols to be available as well.
1
Changes incorporated in this system are the result of a cost reduction effort Changes incorporated in this System are the roomtry to be modified easily.
combined with changes that allow the "look" of the gantry to be interest Combined with chunges that and rain and and acturability and Adultional changes were intorporation to inipes were . These changes were
serviceability as well as to deal with parts obsolescence. (RUC) The City Serviceability as well as to deal with parts esset Handling System (PHS). The CT
limited to the PET gantry as well as the Patient Handling System (PHS). The CT illined to the F LT gamry as well as the reviously commercially available systems.
Indications for Use:
The CPS LSO PET/CT HiRez Series Scanners are combined positron emission The CF S EOO F ETOT Hillson omputed tomography (CT) scannesr. The LSO tomography \r ET/ and X fay oompatible to hegopriately trained health care PET/CT scannel 13 intended to be atlines and measure the distribution of injected positron professionals to 1) image and mound on the purpose of determining various emiling radiophumabodicale in hysiologic functions within the human body, and 2) to metabolic (moleculur) and physiologie landy by computer reconstruction of x-ray produce cross-sectional images of the same axial plane taken at different angles or spiral planes* taken at different angles.
The PET and the CT functions of this system can also be used in combination to The FET and the OT fanstions of this of this cystems maps for PET images and, additionally, utilized to produce fused CT and PET images, images and, adultionally, and metabolic function information in a single image.
(*spiral planes: the axial planes resulted from the continuous rotation of ( Spiral planes. The uxia, pnd the simultaneous translation of the patient.)
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the perimeter. Inside the circle is an abstract image of an eagle or other bird-like figure, with three stylized lines forming the body and wings.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAR 2 5 2005
Ms. M. Alaine Medio, RAC Senior Regulatory Affairs Specialist CTI PET Systems, Inc. 810 Innovation Drive KNOXVILLE TN 37932
Re: K050509 Trade/Device Name: LSO PET/CT HiRez Series Regulation Number: 21 CFR 892.1200 Regulation Name: Emission computed tomography system Regulation Number: 21 CFR 892.1750 Regulation Name: Computed tomography x-ray system Regulatory Class: II Product Code: KPS and JAK Dated: February 28, 2005 Received: March 1, 2005
Dear Ms. Medio:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA 's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
3
This letter will allow you to begin marketing your device as described in your Section 510(k) I his ictief with anow you to begin maneeing your and equivalence of your device to a legally premarket notification: "The PDF mainly of oassification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please 11 you desire specific acvice for your de room of the following numbers, based on the regulation number at the top of this letter:
| 21 CFR 876.xxxx | (Gastroenterology/Renal/Urology) | 240-276-0115 |
|---|---|---|
| 21 CFR 884.xxxx | (Obstetrics/Gynecology) | 240-276-0115 |
| 21 CFR 892.xxxx | (Radiology) | 240-276-0120 |
| Other | 240-276-0100 |
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Also, prease note the regulation entirely information on your responsibilities under the Act from the 807.77). I ou may ootain other generer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Nancy C. Hodgdon
Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
INDICATIONS FOR USE FORM
Page / of /
510(k) Number (if known):
LSO PET/CT HiRez Series Device Name:
Indications for Use:
The CPS LSO PET/CT HiRez Series Scanners are combined positron emission tomography (PET) and X-ray computed tomography (CT) scannesr. The LSO PET/CT scanner is intended to be utilized by appropriately trained health care professionals to 1) image and measure the distribution of injected positron emitting radiopharmaceuticals in humans for the purpose of determining various metabolic (molecular) and physiologic functions within the human body, and 2) to produce cross-sectional images of the body by computer reconstruction of x-ray prounds sion data from either the same axial plane taken at different angles or spiral planes* taken at different angles.
The PET and the CT functions of this system can also be used in combination to provide high resolution, noise free CT attenuation correction maps for PET images and, additionally, utilized to produce fused CT and PET images, providing detailed anatomic and metabolic function information in a single image.
(*spiral planes: the axial planes resulted from the continuous rotation of detectors and x-ray tube and the simultaneous translation of the patient.)
(PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use (Per 21 CFR 801.109)
OR
Over the Counter Use - -
(Optional Format 1-2-96)
Nancy L. Brogdon
Division Sian-Off Division of Reproductive. A and Radiological Devices 510(k) Number .
Page 5